N-acetylneuraminic acid and chondroitin sulfate modified nanomicelles with ROS-sensitive H2S donor via targeting E-selectin receptor and CD44 receptor for the efficient therapy of atherosclerosis (Vol 211, pg 259, 2022)

2024-06-01

0

PRE

AI

DOI：10.1016/j.ijbiomac.2024.132202

Original

Original request for help

Share

Save